About btrec


Brain Tumor-Related Epilepsy

Epilepsy in individuals with brain tumors is quite common – seizures may be the presenting symptom, or may occur later in the course of the disease.

The phenomenon, called brain tumor-related epilepsy (BTRE) represents the combination of two very complicated neurologic disorders – brain tumor and epilepsy.

Whether or not someone with a brain tumor will develop epilepsy depends on multiple factors. The relationship between brain tumors and epilepsy remains incompletely understood.

We propose that
the best way to
approach BTRE
is to treat the
two conditions
from the beginning.

Brain tumor-related epilepsy is managed by neurooncologists, neurosurgeons, epileptologists and other medical professionals.
Patient outcome may well depend on which specialist a patient first encounters. It is the Consortium’s belief that through multi-disciplinary collaboration and improved communication, patient care and outcome will be dramatically enhanced. We aim to standardize care to enhance quality of life of individuals of all ages affected by brain tumor-related epilepsy.



Our Mission:

The mission of the brain tumor related epilepsy consortium is to improve the quality of life of people of all ages with brain tumor-related epilepsy. This mission will be carried out by:

  • conducting and publishing research to better understand the link between brain tumor and epilepsy,
  • providing physician-directed education to patients with brain tumor-related epilepsy,
  • establishing practice parameters in an effort to standardize and improve the care of adult and pediatric patients with tumor-related epilepsy.


The purpose of this multi-disciplinary Consortium is to bring together experts in the fields of epilepsy, neuro-oncology, neuro-surgery, neuropathology, neuro-radiology, neuro-psychology, and basic science to facilitate research in the field of BTRE. By educating healthcare providers and the patient community about the complicated condition of BTRE, we aim to improve quality of life of patients of all ages living with brain tumor-related epilepsy.